Guillen-Navarro, Encarna https://orcid.org/0000-0002-2915-7381
AlSayed, Moeenaldeen
Alves, Inês
Ben-Omran, Tawfeg
Boero, Silvio
Cormier-Daire, Valérie
Fauroux, Brigitte
Fredwall, Svein
Irving, Melita
Kunkel, Philip
Lampe, Christian
Lausch, Ekkehart
Maghnie, Mohamad
Mohnike, Klaus
Mortier, Geert
Pejin, Zagorka
Sessa, Marco
Sousa, Sérgio B.
Funding for this research was provided by:
Ascendis Pharma
BioMarin Pharmaceutical
QED Therapeutics
Pfizer
Sanofi
Article History
Received: 6 December 2023
Accepted: 18 February 2025
First Online: 11 March 2025
Declarations
:
: Not applicable.
: Not applicable.
: IA, TBO, SB, VCD, BF, SF, PK, and GM have no conflict of interest to declare. EGN has received payment or honoraria for lectures/presentations, support for attending meetings and/or travel, and has participated in on a Data Safety Monitoring Board or Advisory Board for BioMarin. MAS has received payment or honoraria for lectures/presentations, support for attending meetings and/or travel from BioMarin and Sanofi, not related to this work. MI has received payment or honoraria for lectures/presentations from BioMarin. CL has received payment or honoraria for lectures/presentations. EL has received grants or contracts from EC and DFG. He has also received consulting fees, payment or honoraria for lectures/presentations, support for attending meetings and/or travel and has participated in a Data Safety Monitoring Board or Advisory Board for BioMarin. MM has received grants or contracts paid to his institution from from Merck Serono, Pfizer, and Novo Nordisk. He has received consulting fees from Novo Nordisk, Pfizer, and BioMarin, as well as payment or honoraria for lectures/presentations from Novo Nordisk, Sandoz, Merck Serono, Pfizer, Ascendis, and BioMarin. KM has received grants or contracts, payment or honoraria for lectures/presentations, support for attending meetings and/or travel and has participated in a Data Safety Monitoring Board or Advisory Board for BioMarin. ZP has received consulting fees and payment or honoraria from Newclip Technics France. MS has received grants or contracts and payment for expert testimony from BioMarin paid to Association AISAC ODV. SS has received grants/contracts from Ascendis and Pfizer. He has also received payment or honoraria for lectures/presentations, support for attending meetings and/or travel, and participated in a Data Safety Monitoring Board or Advisory Board for BioMarin.